Form 4: Integra LifeSciences Executive Mosebrook Reports Stock Transactions
SEC Form 4 Filing
Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences, reports acquisition and disposal of company stock on March 11, 2025.
Summary
- On March 11, 2025, Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences Holdings Corp, reported transactions involving the company's common stock.
- Mosebrook disposed of 134 shares at $23.95 due to tax obligations.
- An additional 309 shares were disposed of at $23.95.
- Mosebrook also acquired 5,514 shares at $0.
- Following these transactions, Mosebrook beneficially owns 40,882 shares of Integra LifeSciences common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports stock transactions by an officer, which is a routine occurrence.
Positives
- The acquisition of 5,514 shares at $0 could be viewed positively.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, depending on how they interpret the insider's actions.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of stock transactions (acquisition and disposal). |
| 03/13/2025 | Date of signature on the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.